SMS Pharmaceuticals Limited (NSE:SMSPHARMA)
India · Delayed Price · Currency is INR 481.00
-2.35 (-0.49%)
Sep 23, 2026, 3:30 PM IST
SMS Pharmaceuticals Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 8,978 | 8,886 | 7,827 | 7,093 | 5,221 | 5,199 |
Revenue Growth | 10.25% | 13.53% | 10.36% | 35.86% | 0.42% | -7.69% |
Gross Profit Gross Profit Growth | 3,110 | 3,039 | 2,640 | 2,109 | 1,321 | 1,890 |
Operating Income Operating Income Growth | 1,327 | 1,338 | 1,049 | 854.71 | 226.98 | 830.73 |
Net Income Net Income Growth | 1,024 | 1,020 | 691.36 | 498.26 | -70.59 | 622.2 |
Earnings Per Share EPS Growth | 11.04 | 11.15 | 8.16 | 5.89 | -0.83 | 7.35 |
EPS Growth | 29.49% | 36.64% | 38.64% | - | - | -0.49% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Exports Exports Growth | 5,960 | 5,428 | 5,089 | 3,258 | 3,268 |
India India Growth | 2,909 | 2,399 | 2,004 | 1,641 | 1,415 |
Total Total Growth | 8,869 | 7,827 | 7,093 | 5,221 | 5,199 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 460.75 | 459.73 | 414.91 | 361.16 | 73.78 | 465.83 |
Total Debt Total Debt Growth | 3,650 | 3,650 | 3,108 | 2,808 | 2,541 | 2,633 |
Net Cash (Debt) Net Cash Growth | -3,190 | -3,191 | -2,693 | -2,447 | -2,467 | -2,167 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -34.40 | -34.90 | -31.79 | -28.90 | -29.14 | -25.60 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 592.24 | 817.09 | 501.25 | 224.5 | 450.6 |
Capital Expenditures CapEx Growth | - | -1,306 | -1,234 | -521.6 | -299.21 | -272.47 |
Free Cash Flow Free Cash Flow Growth | - | -713.35 | -416.71 | -20.35 | -74.71 | 178.12 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 34.64% | 34.20% | 33.73% | 29.74% | 25.30% | 36.35% |
Operating Margin | 14.78% | 15.05% | 13.40% | 12.05% | 4.35% | 15.98% |
Pretax Margin | 14.75% | 14.70% | 12.02% | 9.41% | -1.07% | 12.09% |
Profit Margin | 11.41% | 11.48% | 8.83% | 7.03% | -1.35% | 11.97% |
FCF Margin | - | -8.03% | -5.32% | -0.29% | -1.43% | 3.43% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 23, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.400 | 0.400 | 0.400 | 0.400 | 0.300 | 0.300 |
Dividend Per Share Growth | 0% | 0% | 0% | 33.33% | 0% | 0% |
Dividend Yield | 0.08% | 0.11% | 0.19% | 0.22% | 0.52% | 0.32% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 23, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 43.73 | 34.42 | 27.29 | 30.28 | - | 12.72 |
P/FCF Ratio | - | - | - | - | - | 44.44 |
PS Ratio | 5.04 | 3.95 | 2.41 | 2.13 | 0.95 | 1.52 |